AU2002952524A0 - Epstein barr virus peptide epitopes - Google Patents

Epstein barr virus peptide epitopes

Info

Publication number
AU2002952524A0
AU2002952524A0 AU2002952524A AU2002952524A AU2002952524A0 AU 2002952524 A0 AU2002952524 A0 AU 2002952524A0 AU 2002952524 A AU2002952524 A AU 2002952524A AU 2002952524 A AU2002952524 A AU 2002952524A AU 2002952524 A0 AU2002952524 A0 AU 2002952524A0
Authority
AU
Australia
Prior art keywords
barr virus
peptide epitopes
epstein barr
virus peptide
epstein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002952524A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIMR Berghofer Medical Research Institute
Original Assignee
Queensland Institute of Medical Research QIMR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queensland Institute of Medical Research QIMR filed Critical Queensland Institute of Medical Research QIMR
Priority to AU2002952524A priority Critical patent/AU2002952524A0/en
Publication of AU2002952524A0 publication Critical patent/AU2002952524A0/en
Priority to CN200380102880.3A priority patent/CN1711279B/en
Priority to US10/533,726 priority patent/US20070048329A1/en
Priority to PCT/AU2003/001451 priority patent/WO2004041849A1/en
Priority to AU2003277975A priority patent/AU2003277975A1/en
Priority to TW092130642A priority patent/TW200416043A/en
Priority to HK06104269.0A priority patent/HK1084129A1/en
Abandoned legal-status Critical Current

Links

AU2002952524A 2002-11-07 2002-11-07 Epstein barr virus peptide epitopes Abandoned AU2002952524A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2002952524A AU2002952524A0 (en) 2002-11-07 2002-11-07 Epstein barr virus peptide epitopes
CN200380102880.3A CN1711279B (en) 2002-11-07 2003-11-03 Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor
US10/533,726 US20070048329A1 (en) 2002-11-07 2003-11-03 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
PCT/AU2003/001451 WO2004041849A1 (en) 2002-11-07 2003-11-03 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
AU2003277975A AU2003277975A1 (en) 2002-11-07 2003-11-03 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
TW092130642A TW200416043A (en) 2002-11-07 2003-11-03 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
HK06104269.0A HK1084129A1 (en) 2002-11-07 2006-04-07 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002952524A AU2002952524A0 (en) 2002-11-07 2002-11-07 Epstein barr virus peptide epitopes

Publications (1)

Publication Number Publication Date
AU2002952524A0 true AU2002952524A0 (en) 2002-11-21

Family

ID=28795914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002952524A Abandoned AU2002952524A0 (en) 2002-11-07 2002-11-07 Epstein barr virus peptide epitopes

Country Status (2)

Country Link
CN (1) CN1711279B (en)
AU (1) AU2002952524A0 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101066990B (en) * 2007-04-27 2010-07-07 郑州大学 Antitumor CTL epitope peptide possessing population broad spectrum property
BR112013027457A2 (en) * 2011-04-28 2019-09-24 Int Medica Foundation vaccine preparation, and methods of making a vaccine preparation, and of vaccinating a mammal
WO2016095783A1 (en) * 2014-12-17 2016-06-23 中国科学院广州生物医药与健康研究院 T cell receptor for identifying eb virus short peptide
CN112125959B (en) * 2020-10-10 2022-07-29 中山大学肿瘤防治中心 Peptide for inhibiting EB virus, DNA for coding peptide and application thereof

Also Published As

Publication number Publication date
CN1711279A (en) 2005-12-21
CN1711279B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
PL371007A1 (en) Macrocyclic peptides active against the hepatitis c virus
HK1084129A1 (en) Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
AU3328900A (en) Influenza virus hemagglutinin-binding peptides
AU2003206862A1 (en) Hepatitis b vaccines
AU2003290563A1 (en) Leptin-related peptides
EP1578787A4 (en) Novel chi-conotoxin peptides (-ii)
EP1268518A4 (en) Insulin potentiating peptides
EP1558628A4 (en) Antigenic peptides
AU2003294220A1 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
GB0100196D0 (en) Peptides
AU2003228863A1 (en) Immunogenic peptides
EP1499635B8 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
AU2002952524A0 (en) Epstein barr virus peptide epitopes
AU2003293807A1 (en) Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
GB0109438D0 (en) Peptides
AU2003221569A1 (en) Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
AUPS084502A0 (en) Anti-protozoal vaccine
AU2003276846A1 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity
AU2003225479A1 (en) Reporter-selectable hepatitis c virus replicon
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2003267971A1 (en) Improved alphavirus vectors having attenuated virion structural proteins
AU2003901792A0 (en) Epstein barr virus peptide epitopes, polyepitopes & delivery system therefor
AU2003240866A1 (en) Antibodies, peptides and vaccines against hiv-1 virus
AU2002351795A1 (en) Hepatitis x virus antigen
AU2002328853A1 (en) Carcinoma-related peptides